Marker and probe composition for screening liver cancer and application of marker and probe composition
A technology of markers and compositions, applied in the fields of application, combinatorial chemistry, organic compound library, etc., can solve the problem of reducing the 5-year total mortality rate of liver cancer, achieve high sensitivity and accuracy, and reduce the effect of harm
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0146] The preparation of the chip is mainly based on a glass sheet or a silicon sheet as a carrier, and oligonucleotide fragments or cDNAs are arranged on the carrier in sequence as probes by means of in situ synthesis and micro-array.
[0147] The chip of the present invention is based on the signal detection of DNA sequence hybridization after bisulfite treatment. Bisulfite treatment is to change unmethylated cytosine into uracil, while methylated cytosine remains unchanged. Change, then convert uracil to thymine, and finally carry out chip hybridization; finally judge the type of base added according to the fluorescent color, and then determine whether the site is methylated.
[0148] The present invention provides a method for liver cancer screening, which comprises:
[0149] detect the methylation level of the marker, and
[0150] The risk of the subject suffering from liver cancer is judged based on the methylation level, and the marker is selected from one of the foll...
Embodiment 1
[0153] Example 1 Screening markers
[0154] 1) Sample collection: Download the 450k methylation microarray cancer tissue data in TCGA, involving a total of 7,769 cancer tissue samples of 26 types of tumors, including adrenocortical carcinoma (80), bladder urothelial carcinoma (409), acute myeloid Leukemia (140), brain low-grade glioma (654), breast cancer (740), cervical cancer (286), liver cancer (348), esophageal cancer (183), uveal melanoma (80), head and neck squamous cell Carcinoma (527), kidney cancer (660), liver cancer (377), lung adenocarcinoma (425), lung squamous cell carcinoma (372), diffuse large B-cell lymphoma (29), ovarian serous cystadenocarcinoma (10) , pancreatic cancer (184), mesothelioma (116), prostate cancer (488), skin melanoma (104), sarcoma (117), gastric cancer (397), testicular cancer (134), thymus cancer (94), thyroid cancer cancer (506), endometrial cancer (309). For the healthy population, Boercheng collected the plasma of 38 healthy individual...
Embodiment 2
[0319] Based on 15 clinically diagnosed liver cancer samples collected from the Beijing area and 15 healthy human samples collected from the Beijing area, the 9 methylated biomarkers were calculated and screened using the methylation database construction method described in Example 1 According to the methylation level of the 9 methylation biomarkers in the liver cancer sample and normal human sample data sets, the threshold value (hereinafter referred to as the site or marker) and the AUC value for independent distinction are calculated in the table 18;
[0320] The calculation method of the methylation level threshold is: according to the data set (including the type and methylation level of each sample), the ROC curve is drawn, and the confusion matrix corresponding to the optimal threshold point on the ROC curve will be our calculated sensitivity ( sensitivity), specificity, and accuracy. Normally, we will use the Youden index to make selections. Youden index, also known...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com